Skip to content

Evaluation of Anesthesia Effect of Ciprofol ERCP Operation

Evaluation of Anesthesia Effect of Ciprofol ERCP Operation

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055629
Enrollment
Unknown
Registered
2022-01-15
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gallstones

Interventions

Experimental group:Induction of Anesthesia with Ciprofol
Control group:Induction of anesthesia with propofol

Sponsors

The First Hospital of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-60 years, gender is not limited; 2. Body mass index (BMI) of 19-26 kg/m2; 3. American Class of Anesthesiologists (ASA) I-II; 4. Patients scheduled for general anesthesia induction by endoscopic retrograde cholangiopancreatography; 5. Vital signs: respiratory rate >= 10 and = 95% when breathing air; systolic blood pressure (SBP) >= 90 mmHg and = 60 mmHg and = 55 and <= 100 beats/min; 6. I or my family members can understand the process and methods of this research, and voluntarily participate in this research.

Exclusion criteria

Exclusion criteria: 1. Those with contraindications to general anesthesia or those with a history of anesthesia accidents in the past; 2. Those who are known or suspected to be allergic or contraindicated to propofol injection, cyclopofol injection excipients, benzodiazepines, opioids, muscle relaxants, etc.; 3. Combined with brain loss, intracranial hypertension, stroke, unstable angina, myocardial infarction; 4. Respiratory insufficiency, obstructive pulmonary disease, difficult airway or difficulty in tracheal intubation (modified Martens score is grade III or IV); 5. Uncontrolled diabetes or high blood pressure; 6. Severe liver dysfunction or severe renal insufficiency; 7. History of alcoholism or drug dependence; 8. Abusing or long-term use of narcotics, sedatives, and analgesics; 9. Those with a history of mental illness; 10. Those who have participated in any drug clinical trials within one month before screening; 11. Pregnant and breastfeeding women; women or men with reproductive potential who are unwilling to use contraception throughout the test period; subjects (including male subjects) who have a pregnancy plan within 1 month after the test; 12. Subjects who, in the investigator's opinion, have any other factors that are not suitable for participating in this trial.

Design outcomes

Primary

MeasureTime frame
Success rate of general anesthesia induction;

Countries

China

Contacts

Public ContactLiu Yatao

The First Hospital of Lanzhou University

doctorliuyt@163.com+86 18152107860

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026